Skip to main content
AJNR: American Journal of Neuroradiology logoLink to AJNR: American Journal of Neuroradiology
. 2015 May;36(5):E39–E40. doi: 10.3174/ajnr.A4307

Erratum

PMCID: PMC7990614  PMID: 25857758

The original versions of Tables 1–4 that were contained in the article “International Retrospective Study of the Pipeline Embolization Device: A Multicenter Aneurysm Treatment Study” by D.F. Kallmes, R. Hanel, D. Lopes et al (AJNR Am J Neuroradiol 2015;36:108–15, originally published on-line on October 29, 2014, 10.3174/ajnr.A4111) contained errors. Due to a coding problem, 36 PICA and vertebral artery aneurysms were changed from “anterior” to “posterior.” In addition, 17 ICA aneurysms were changed from “other anterior” to “ICA.” The authors state that these changes do not affect the conclusions or clinical implications of their paper. The only outcome that changed in statistical significance was the comparison of the rates of neurologic mortality and neurologic morbidity + mortality between anterior and posterior circulation aneurysms at >30 days (Table 3). These are the corrected tables.

Table 1:

Aneurysm characteristics

Aneurysm Characteristics Anterior ICA ≥10 mm Anterior ICA <10 mm Posterior Other Anterior P Value Total
Aneurysm size (mm) <.0001
    Mean ± SD (n) 16.8 ± 6.3 (317) 5.2 ± 2.2 (360) 13.8 ± 8.4 (93) 9.2 ± 8.0 (126) 10.7 ± 7.7 (896)
    Median, range 15.0, 10.0–42.0 5.0, 1.0–10.0 11.6, 1.5–45.0 6.7, 1.0–55.0 9.0, 1.0–55.0
Aneurysm type <.0001
    Small 0.0% (0/317) 100.0% (360/360) 35.5% (33/93) 63.5% (80/126) 52.8% (473/896)
    Large 85.8% (272/317) 0.0% (0/360) 49.5% (46/93) 31.0% (39/126) 39.8% (357/896)
    Giant 14.2% (45/317) 0.0% (0/360) 15.1% (14/93) 5.6% (7/126) 7.4% (66/896)
Aneurysm neck (mm) <.0001
    Mean ± SD (n) 8.5 ± 5.0 (297) 4.1 ± 2.2 (335) 8.7 ± 7.5 (70) 4.8 ± 5.1 (110) 6.2 ± 4.9 (812)
    Median, range 7.6, 0.9–50.0 3.9, 0.8–22.0 6.6, 1.7–53.0 3.9, 1.0–50.0 5.0, 0.8–53.0
Aneurysm shape <.0001
    Saccular 77.3% (245/317) 87.8% (316/360) 35.8% (34/95) 71.7% (91/127) 76.0% (689/906)
    Fusiform 15.5% (49/317) 4.7% (17/360) 29.5% (28/95) 15.0% (19/127) 12.8% (116/906)
    Dissecting 3.2% (10/317) 2.2% (8/360) 28.4% (27/95) 7.1% (9/127) 6.0% (54/906)
    Other 4.1% (13/317) 5.3% (19/360) 6.3% (6/95) 6.3% (8/127) 5.2% (47/906)
Aneurysm location <.0001
    Internal carotid artery 100.0% (317/317) 100.0% (360/360) 0.0% (0/95) 0.0% (0/127) 75.5% (684/906)
    Middle cerebral artery 0.0% (0/317) 0.0% (0/360) 0.0% (0/95) 33.9% (43/127) 4.7% (43/906)
    Posterior cerebral artery 0.0% (0/317) 0.0% (0/360) 15.8% (15/95) 0.0% (0/127) 1.7% (15/906)
    Basilar artery 0.0% (0/317) 0.0% (0/360) 46.3% (44/95) 0.0% (0/127) 4.9% (44/906)
    Other 0.0% (0/317) 0.0% (0/360) 37.9% (36/95) 66.1% (84/127) 13.2% (120/906)
Presented with ruptured aneurysm 3.8% (12/317) 6.7% (24/360) 7.4% (7/95) 25.2% (32/127) <.0001 8.4% (76/906)
Multiple PEDs utilized 45.4% (144/317) 27.4% (98/358) 37.9% (36/95) 22.8% (29/127) <.0001 34.1% (308/904)

Table 2:

Complications by aneurysm location and size subgroups

Patient Characteristics Anterior ICA ≥10 mm Anterior ICA <10 mm Posterior Other Anterior P Value Total 95% CI
Aneurysm size (mm) <.0001 (10.7–11.8)
    Mean ± SD (n) 16.8 ± 6.3 (296) 5.3 ± 2.2 (291) 14.2 ± 8.5 (88) 9.7 ± 8.3 (112) 11.2 ± 7.8 (787)
    Median, range 15.0, 10.0–42.0 5.0, 1.2–10.0 12.0, 1.5–45.0 7.1, 1.0–55.0 10.0, 1.0–55.0
Spontaneous rupture 1.4% (4/296) 0.0% (0/291) 1.1% (1/90) 0.0% (0/112) .1657 0.6% (5/793) (0.2%–1.5%)
Intracranial hemorrhage 2.7% (8/296) 1.4% (4/291) 2.2% (2/90) 5.4% (6/112) .2299 2.5% (20/793) (1.6%–3.9%)
Ischemic stroke 5.4% (16/296) 2.4% (7/291) 6.7% (6/90) 6.3% (7/112) .1726 4.5% (36/793) (3.2%–6.2%)
Parent artery stenosis 0.3% (1/296) 0.3% (1/291) 0.0% (0/90) 0.0% (0/112) 1.0000 0.3% (2/793) (0.0%–0.9%)
Cranial neuropathy 0.7% (2/296) 0.0% (0/291) 0.0% (0/90) 0.0% (0/112) .7257 0.3% (2/793) (0.0%–0.9%)
Neurologic morbidity 8.8% (26/296) 4.1% (12/291) 8.9% (8/90) 11.6% (13/112) .0496 7.4% (59/793) (5.7%–9.5%)
Neurologic mortality 3.7% (11/296) 1.4% (4/291) 7.8% (7/90) 7.1% (8/112) .0108 3.8% (30/793) (2.6%–5.4%)
Neurologic morbidity and mortality (all patients) 9.5% (28/296) 4.1% (12/291) 13.3% (12/90) 13.4% (15/112) .0046 8.4% (67/793) (6.6%–10.6%)
Neurologic morbidity and mortality (patients with unruptured aneurysms) 9.5% (27/285) 3.4% (9/268) 12.0% (10/83) 9.9% (8/81) .0104 7.5% (54/720) (5.7%–9.7%)
Neurologic morbidity and mortality (patients with ruptured aneurysms) 16.7% (2/12) 12.5% (3/24) 28.6% (2/7) 21.9% (7/32) .7639 18.4% (14/76) (10.5%–29.0%)
Neurologic morbidity and mortality (excluding ruptured, dissecting, or fusiform aneurysms) 7.7% (18/233) 3.6% (9/253) 8.6% (3/35) 9.7% (6/62) .1343 6.2% (36/585) (4.4%–8.4%)

Table 3:

Occurrence of complication by time

Major Complications <72 Hours
72 Hours–30 Days
>30 Days
P Value Total
Anterior Posterior Anterior Posterior Anterior Posterior
Spontaneous rupture 0.1% (1/703) 0.0% (0/90) 0.3% (2/703) 1.1% (1/90) 0.1% (1/703) 0.0% (0/90) .6290 0.6% (5/793)
Intracranial hemorrhage 0.4% (3/703) 2.2% (2/90) 1.6% (11/703) 0.0% (0/90) 0.6% (4/703) 0.0% (0/90) .1363 2.5% (20/793)
Ischemic stroke 2.1% (15/703) 3.3% (3/90) 0.9% (6/703) 2.2% (2/90) 1.3% (9/703) 1.1% (1/90) .1102 4.5% (36/793)
Parent artery stenosis 0.0% (0/703) 0.0% (0/90) 0.1% (1/703) 0.0% (0/90) 0.1% (1/703) 0.0% (0/90) 1.0000 0.3% (2/793)
Cranial neuropathy 0.0% (0/703) 0.0% (0/90) 0.3% (2/703) 0.0% (0/90) 0.0% (0/703) 0.0% (0/90) .3331 0.3% (2/793)
Neurologic morbidity 2.6% (18/703) 5.6% (5/90) 2.8% (20/703) 2.2% (2/90) 1.8% (13/703) 1.1% (1/90) .2757 7.4% (59/793)
Neurologic mortality 1.0% (7/703) 3.3% (3/90) 1.4% (10/703) 2.2% (2/90) 0.9% (6/703) 2.2% (2/90) .7014 3.8% (30/793)
Neurologic morbidity and mortality (all patients) 2.8% (20/703) 5.6% (5/90) 3.1% (22/703) 4.4% (4/90) 1.8% (13/703) 3.3% (3/90) .2543 8.4% (67/793)
Neurologic morbidity and mortality (patients with unruptured aneurysms) 2.5% (16/637) 6.0% (5/83) 2.7% (17/637) 3.6% (3/83) 1.7% (11/637) 2.4% (2/83) .3511 7.5% (54/720)
Neurologic morbidity and mortality (patients with ruptured aneurysms) 5.8% (4/69) 0.0% (0/7) 8.7% (6/69) 14.3% (1/7) 2.9% (2/69) 14.3% (1/7) .4768 18.4% (14/76)
Neurologic morbidity and mortality (excluding ruptured, dissecting, or fusiform aneurysms) 2.5% (14/550) 2.9% (1/35) 2.5% (14/550) 2.9% (1/35) 0.9% (5/550) 2.9% (1/35) .0934 6.2% (36/585)

Table 4:

Complication by aneurysm size

Major Complications Small
Large
Giant
P Value Total
Anterior Posterior Anterior Posterior Anterior Posterior
Aneurysm size (mm) <.0001
    Mean ± SD (n) 5.3 ± 2.2 (360) 6.1 ± 2.5 (27) 14.8 ± 4.1 (292) 14.8 ± 4.1 (46) 29.2 ± 5.6 (49) 28.5 ± 6.2 (14) 11.3 ± 7.7 (788)
    Median, range 5.0, 1.0–10.0 6.3, 1.5–9.4 14.0, 10.0–24.5 14.3, 10.0–23.0 27.0, 25.0–55.0 26.0, 25.0–45.0 10.0, 1.0–55.0
Spontaneous rupture 0.0% (0/360) 0.0% (0/27) 0.7% (2/292) 0.0% (0/46) 4.1% (2/49) 7.1% (1/14) .0011 0.6% (5/793)
Intracranial hemorrhage 1.9% (7/360) 0.0% (0/27) 2.7% (8/292) 2.2% (1/46) 6.1% (3/49) 7.1% (1/14) .0901 2.5% (20/793)
Ischemic stroke 2.8% (10/360) 0.0% (0/27) 4.8% (14/292) 4.3% (2/46) 12.2% (6/49) 21.4% (3/14) .0008 4.5% (36/793)
Parent artery stenosis 0.3% (1/360) 0.0% (0/27) 0.3% (1/292) 0.0% (0/46) 0.0% (0/49) 0.0% (0/14) 1.0000 0.3% (2/793)
Cranial neuropathy 0.0% (0/360) 0.0% (0/27) 0.7% (2/292) 0.0% (0/46) 0.0% (0/49) 0.0% (0/14) .3373 0.3% (2/793)
Neurologic morbidity 5.0% (18/360) 0.0% (0/27) 7.5% (22/292) 6.5% (3/46) 22.4% (11/49) 28.6% (4/14) <.0001 7.4% (59/793)
Neurologic mortality 1.7% (6/360) 3.7% (1/27) 4.8% (14/292) 6.5% (3/46) 6.1% (3/49) 21.4% (3/14) .0033 3.8% (30/793)
Neurologic morbidity and mortality (all patients) 5.3% (19/360) 3.7% (1/27) 8.6% (25/292) 10.9% (5/46) 22.4% (11/49) 35.7% (5/14) <.0001 8.4% (67/793)
Neurologic morbidity and mortality (patients with unruptured aneurysms) 3.5% (11/311) 0.0% (0/24) 7.9% (22/277) 11.4% (5/44) 22.9% (11/48) 30.8% (4/13) <.0001 7.5% (54/720)
Neurologic morbidity and mortality (patients with ruptured aneurysms) 16.0% (8/50) 33.3% (1/3) 18.8% (3/16) 0.0% (0/2) 50.0% (1/2) 100.0% (1/1) .1385 18.4% (14/76)
Neurologic morbidity and mortality (excluding ruptured, dissecting, or fusiform aneurysms) 3.8% (11/293) 0.0% (0/12) 6.4% (14/218) 11.8% (2/17) 20.5% (8/39) 20.0% (1/5) .0005 6.2% (36/585)

Articles from AJNR: American Journal of Neuroradiology are provided here courtesy of American Society of Neuroradiology

RESOURCES